STUDY SEARCH RESULTS

2 studies found for your search request:  3475-966

Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin versus Placebo Plus Gemcitabine/Cisplatin for Fir...
Condition: Biliary Tract Carcinoma
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT04003636
Status: Active, not recruiting
Has Results

Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin versus Placebo Plus Gemcitabine/Cisplatin for Fir...
Condition: Biliary Tract Carcinoma
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT04924062
Status: Active, not recruiting
Has Results




Copyright © 2024 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  U.S. Corporate Site